Laura Morrison
Royal Marsden NHS Foundation Trust(GB)Institute of Cancer Research(GB)Breast Cancer Now(GB)Royal Marsden Hospital(GB)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, Breast Cancer Treatment Studies, Urinary and Genital Oncology Studies, Advanced Breast Cancer Therapies
Most-Cited Works
- → The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment(2023)219 cited
- → The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma(2018)49 cited
- → Biomarker challenges for immune checkpoint inhibitors in urothelial carcinoma(2018)35 cited
- → Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions(2023)23 cited
- → Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma(2020)3 cited
- → First-line PD-1/PD-L1 inhibitor followed by carboplatin (carbo)-based chemotherapy (chemo) or the reverse sequence in cisplatin-ineligible metastatic urothelial cancer (mUC) patients (pts).(2018)3 cited